Fairmount Healthcare Fund II LP acquires 853,450 Crescent Biopharma shares for $12.38 million
Share
Listen to the news
Fairmount Healthcare Fund II LP acquires 853,450 Crescent Biopharma shares for $12.38 million
  • Fairmount Healthcare Fund II bought 853,450 Crescent Biopharma ordinary shares at $14.5, lifting its stake to 3,601,316 shares.
  • The fund also bought 525,897 Pre-Funded Warrants at $14.5, taking its warrant position to 2,294,037.
  • Tomas Kiselak, managing member of Fairmount Funds Management, was listed as a reporting person on the filing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crescent Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-085113), on July 20, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending